346 related articles for article (PubMed ID: 24077291)
1. Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner.
Lim KS; Lim KJ; Price AC; Orr BA; Eberhart CG; Bar EE
Oncogene; 2014 Aug; 33(35):4433-41. PubMed ID: 24077291
[TBL] [Abstract][Full Text] [Related]
2. Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.
Todenhöfer T; Seiler R; Stewart C; Moskalev I; Gao J; Ladhar S; Kamjabi A; Al Nakouzi N; Hayashi T; Choi S; Wang Y; Frees S; Daugaard M; Oo HZ; Fisel P; Schwab M; Schaeffeler E; Douglas J; Hennenlotter J; Bedke J; Gibb EA; Fazli L; Stenzl A; Black PC
Mol Cancer Ther; 2018 Dec; 17(12):2746-2755. PubMed ID: 30262589
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral Distribution of Lactate and the Monocarboxylate Transporters 1 and 4 in Human Glioblastoma Multiforme and Their Relationships to Tumor Progression-Associated Markers.
Kubelt C; Peters S; Ahmeti H; Huhndorf M; Huber L; Cohrs G; Hövener JB; Jansen O; Synowitz M; Held-Feindt J
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872409
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression.
Voss DM; Spina R; Carter DL; Lim KS; Jeffery CJ; Bar EE
Sci Rep; 2017 Jun; 7(1):4292. PubMed ID: 28655889
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes.
Pérez de Heredia F; Wood IS; Trayhurn P
Pflugers Arch; 2010 Feb; 459(3):509-18. PubMed ID: 19876643
[TBL] [Abstract][Full Text] [Related]
6. Oxygen tension controls the expression of the monocarboxylate transporter MCT4 in cultured mouse cortical astrocytes via a hypoxia-inducible factor-1α-mediated transcriptional regulation.
Rosafio K; Pellerin L
Glia; 2014 Mar; 62(3):477-90. PubMed ID: 24375723
[TBL] [Abstract][Full Text] [Related]
7. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.
Miranda-Gonçalves V; Granja S; Martinho O; Honavar M; Pojo M; Costa BM; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Reis RM; Baltazar F
Oncotarget; 2016 Jul; 7(29):46335-46353. PubMed ID: 27331625
[TBL] [Abstract][Full Text] [Related]
9. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis.
Kim HK; Lee I; Bang H; Kim HC; Lee WY; Yun SH; Lee J; Lee SJ; Park YS; Kim KM; Kang WK
Mol Cancer Ther; 2018 Apr; 17(4):838-848. PubMed ID: 29483215
[TBL] [Abstract][Full Text] [Related]
10. Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments.
Contreras-Baeza Y; Sandoval PY; Alarcón R; Galaz A; Cortés-Molina F; Alegría K; Baeza-Lehnert F; Arce-Molina R; Guequén A; Flores CA; San Martín A; Barros LF
J Biol Chem; 2019 Dec; 294(52):20135-20147. PubMed ID: 31719150
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma.
Long Y; Gao Z; Hu X; Xiang F; Wu Z; Zhang J; Han X; Yin L; Qin J; Lan L; Yin F; Wang Y
Cancer Med; 2018 Sep; 7(9):4690-4700. PubMed ID: 30051648
[TBL] [Abstract][Full Text] [Related]
12. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism.
Ullah MS; Davies AJ; Halestrap AP
J Biol Chem; 2006 Apr; 281(14):9030-7. PubMed ID: 16452478
[TBL] [Abstract][Full Text] [Related]
13. Prolonged hypoxia induces monocarboxylate transporter-4 expression in mesenchymal stem cells resulting in a secretome that is deleterious to cardiovascular repair.
Saraswati S; Guo Y; Atkinson J; Young PP
Stem Cells; 2015 Apr; 33(4):1333-44. PubMed ID: 25537659
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P
Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421
[TBL] [Abstract][Full Text] [Related]
15. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human monocarboxylate transporter 4 in skeletal muscle cells: the role of protein kinase C (PKC).
Narumi K; Kobayashi M; Otake S; Furugen A; Takahashi N; Ogura J; Itagaki S; Hirano T; Yamaguchi H; Iseki K
Int J Pharm; 2012 May; 428(1-2):25-32. PubMed ID: 22426323
[TBL] [Abstract][Full Text] [Related]
17. Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.
Fujii W; Kawahito Y; Nagahara H; Kukida Y; Seno T; Yamamoto A; Kohno M; Oda R; Taniguchi D; Fujiwara H; Ejima A; Kishida T; Mazda O; Ashihara E
Arthritis Rheumatol; 2015 Nov; 67(11):2888-96. PubMed ID: 26213210
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.
Bar EE; Lin A; Mahairaki V; Matsui W; Eberhart CG
Am J Pathol; 2010 Sep; 177(3):1491-502. PubMed ID: 20671264
[TBL] [Abstract][Full Text] [Related]
19. The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages.
Tan Z; Xie N; Banerjee S; Cui H; Fu M; Thannickal VJ; Liu G
J Biol Chem; 2015 Jan; 290(1):46-55. PubMed ID: 25406319
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
